Sponsor:
National Cancer Institute (NCI)
Code:
NCT05907746
Conditions
GATA2
Immunodeficiency
Eligibility Criteria
Sex: All
Age: 6 - 70
Healthy Volunteers: Not accepted
Interventions
Mycophenolate Mofetil
Tacrolimus
Post-Transplant Cyclophosphamide
Total Body Irradiation
Hematopoietic Cell Transplant
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations